13F Pro13F Pro

VILLERE ST DENIS J & CO LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1113629
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare22.0%$184.6M
  • Financials19.6%$164.2M
  • Technology14.6%$122.4M
  • Consumer Discretionary9.2%$77.0M
  • Consumer Staples7.6%$63.4M
  • Industrials7.0%$58.9M
  • Energy6.3%$53.2M
  • Other3.3%$27.8M
  • Materials3.2%$26.9M
  • Real Estate3.2%$26.7M

AUM History

13fpro.ai/research/fund/villere-st-denis-j-and-co-llc-1113629

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/villere-st-denis-j-and-co-llc-1113629

VILLERE ST DENIS J & CO LLC 13F holdings — Q2 2026

$837.8M portfolio (-7.6% QoQ) · 85 holdings · Q2 2026 13F · top 10 are 38% of the stock portfolio

All holdings — VILLERE ST DENIS J & CO LLC (Q2 2026)

85 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
LMT$LMTLOCKHEED MARTIN CORP$25.5M-8%
AESI$AESIAtlas Energy Solutions Inc.$22.4M-27%
ON$ONON SEMICONDUCTOR CORP$22.3M-32%
FIBK$FIBKFIRST INTERSTATE BANCSYSTEM INC$21.9M-9%
POOL$POOLPOOL CORP$20.9M-17%
BAC$BACBANK OF AMERICA CORP /DE/preferred$20.7M-11%
ONON$ONONOn Holding AG$20.7M-5%
STE$STESTERIS plc$20.6M-10%
SYK$SYKSTRYKER CORP$20.3M-14%
ABT$ABTABBOTT LABORATORIES$18.9M-9%
MCHP$MCHPMICROCHIP TECHNOLOGY INC$17.9M-42%
IDXX$IDXXIDEXX LABORATORIES INC /DE$17.8M-13%
CL$CLCOLGATE PALMOLIVE CO$17.7M-15%
ROP$ROPROPER TECHNOLOGIES INC$17.6M-10%
PGR$PGRPROGRESSIVE CORP/OH/$17.4M-9%

What changed in Q2 2026

Against the previous quarter's 13F: 12 new, 4 added to, 45 trimmed, 3 sold out. Share-count changes; largest moves by dollar size first.

New positions (12)

  • SCHWAB STRATEGIC TR - US LCAP GR ETF$8.4M

    first bought this quarter

  • SCHWAB STRATEGIC TR - US LCAP VA ETF$4.7M

    first bought this quarter

  • SCHWAB STRATEGIC TR - US MID-CAP ETF$3.3M

    first bought this quarter

  • SCHWAB STRATEGIC TR - US DIVIDEND EQ$2.3M

    first bought this quarter

  • SCHWAB STRATEGIC TR - INTERNL DIVID$1.4M

    first bought this quarter

  • SCHWAB STRATEGIC TR - US REIT ETF$880K

    first bought this quarter

+6 more in the Excel export

Added to (4)

  • RELY$RELYRemitly Global, Inc.+40%

    now $784K · held 2 qtrs, 2 adds in a row

  • GLD$GLDSPDR GOLD TRUST+25%

    now $374K · held 8 qtrs

  • WMT$WMTWalmart Inc.+2%

    now $346K · held 10+ qtrs

  • PROSHARES TR - BITCOIN ETF+0.3%

    now $101K

Trimmed (45)

  • CZR$CZRCaesars Entertainment, Inc.-91%

    now $2.5M · held 10+ qtrs, 3 trims in a row

  • MCHP$MCHPMICROCHIP TECHNOLOGY INC-42%

    now $17.9M · held 10+ qtrs, 5 trims in a row

  • LGND$LGNDLIGAND PHARMACEUTICALS INC-18%

    now $49.2M · held 10+ qtrs, 4 trims in a row

  • ON$ONON SEMICONDUCTOR CORP-32%

    now $22.3M · held 10+ qtrs, 9 trims in a row

  • AESI$AESIAtlas Energy Solutions Inc.-27%

    now $22.4M · held 10+ qtrs, 3 trims in a row

  • V$VVISA INC.-14%

    now $34.3M · held 10+ qtrs, 9 trims in a row

+39 more in the Excel export

Sold out (3)

  • SCHWAB STRATEGIC TRwas $487K
  • TALK$TALKTalkspace, Inc.was $243K

    held 3 qtrs

  • COST$COSTCOSTCO WHOLESALE CORP /NEWwas $211K

    held 1 qtr

Holdings by quarter

Every 13F VILLERE ST DENIS J & CO LLC has filed, 41 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow VILLERE ST DENIS J?

Q2 2026 13F filed with the SEC on Aug 7, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of VILLERE ST DENIS J's top 20 holdings: 65/100 (our AI quality score, weighted by position size; 19 of the 20 are scored)

Top 10 since filing

+2.5%

Value-weighted move of the 10 largest stock positions

Turnover

3%

Last quarter; 8% over the last 4

Top 10 weight

38%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

100%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

VILLERE ST DENIS J & CO LLC disclosed 85 positions worth $837.8M in its Form 13F-HR for Q2 2026, led by $LGND (LIGAND PHARMACEUTICALS INC) at 5.9% of the equity portfolio, followed by $JPM and $V. During the quarter the fund opened 12 new positions and exited 3. The portfolio is most concentrated in Healthcare (22.0% of disclosed assets). All figures are sourced directly from VILLERE ST DENIS J & CO LLC’s Form 13F-HR filing with the SEC under CIK 1113629.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: VILLERE ST DENIS J & CO LLC

13F Pro is an AI hedge fund tracker and stock research platform. For VILLERE ST DENIS J & CO LLC (SEC CIK: 1113629), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in VILLERE ST DENIS J & CO LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.